Business Context and Reporting Period
This Form 8-K Current Report was filed by TherapeuticsMD, Inc. on February 29, 2012. The filing addresses significant changes in corporate governance and management, specifically the expansion of the Board of Directors and the establishment of formal board committees.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the election of four new directors to the Board of Directors on February 29, 2012:
- Samuel A. Greco: Former CEO of CareView Communications, Inc., with over 30 years of hospital administration experience, including financial operations at Columbia/HCA Healthcare Corporation.
- Cooper C. Collins: Former President and CEO of Pernix Therapeutics Holdings, Inc., with extensive experience in specialty pharmaceuticals and product development.
- Robert V. LaPenta, Jr.: Partner at Aston Capital and former VP of Mergers and Acquisitions at L-1 Identity Solutions, Inc., with a background in equity trading and private equity.
- Nicholas Segal: Director of Seavest Capital Partners and CEO of Polar Generation, LLC, with experience in early-stage investments in healthcare and consumer technology.
Existing directors Robert G. Finizio, John C.K. Milligan IV, and Brian Bernick will continue to serve.
Corporate Governance and Committee Structure
On February 29, 2012, the Board approved charters and appointed members for three key committees:
- Audit Committee: Chaired by Robert V. LaPenta, Jr., with members Samuel A. Greco and Nicholas Segal. Responsible for oversight of financial statements, internal controls, and auditor independence.
- Compensation Committee: Chaired by Cooper C. Collins, with members Robert G. Finizio and Nicholas Segal. Responsible for executive compensation policies.
- Corporate Governance Committee: Chaired by John C.K. Milligan, IV, with members Brian Bernick and Robert LaPenta, Jr. Responsible for identifying board candidates and developing governance principles.
Investor Verification Checklist
- Verify the specific terms of the new directors' service (expire at the next Annual Meeting of Shareholders).
- Review the attached exhibits (10.0, 10.1, 10.2) for the full text of the Audit, Compensation, and Corporate Governance Committee Charters.
- Confirm the independence status of the new directors relative to the company's existing operations and related parties.
- Check for any subsequent filings regarding the impact of these governance changes on strategic direction or capital raising efforts.